Ambarella Inc (NASDAQ: AMBA) delivered
some impressive Q2 numbers on Thursday. Despite the market’s negative reaction, Canaccord analyst Matthew Ramsay remains bullish on
the stock.
Ambarella delivered non-GAAP EPS of $0.54 on revenue of $65.1 million in Q2. Both numbers beat consensus analyst expectations of
$0.38 and $64.3 million, respectively.
Ambarella shares are down 6.3 percent in Fridays session, and the company’s guidance may be to blame. However, Ramsay
appreciates the company’s conservative approach to setting market expectations.
“Despite the near-term hurdles, our long-term conviction regarding Ambarella’s leading technology position in several growing
end markets including wearable, security, automotive, and drone cameras remains intact, and we believe long-term investors will be
rewarded as new design wins ramp and the launch of new 14nm chipsets next year return the company to solid Y/Y sales/earnings
growth,” he explained.
Related Link: GoPros
And Drones Bullish For Ambarella, KeyBanc Says
Ramsay was particularly impressed with Ambarella’s Q2 strength given the well-known headwinds from GoPro Inc
(NASDAQ: GPRO)'s slumping sales and Sony Corp
(ADR) (NYSE: SNE)’s image sensor supply.
Canaccord predicts strong home security and drone camera growth ahead for Ambarella, and Ramsay noted that OEM camera sales
could end up as Ambarella’s largest long-term market opportunity.
Canaccord reiterated its Buy rating on Ambarella and upped its price target from $85 to $86.
At time of publication, Ambarella shares were down 6.76 percent on the day, trading at $66.93.
Full ratings
data available on Benzinga Pro.
Do you have ideas for articles/interviews you'd like to see more of on Benzinga? Please email feedback@benzinga.com with your best article ideas. One person will be randomly selected to win
a $20 Amazon gift card!
Latest Ratings for AMBA
Date |
Firm |
Action |
From |
To |
Aug 2016 |
KeyBanc |
Maintains |
|
Overweight |
Jun 2016 |
Deutsche Bank |
Maintains |
|
Hold |
Apr 2016 |
Oppenheimer |
Initiates Coverage on |
|
Perform |
View More Analyst Ratings for
AMBA
View the Latest Analyst Ratings
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.